Percutaneous coronary intervention, commonly known as angioplasty with a stent, opens clogged arteries and saves lives. Despite its benefit in treating atherosclerosis, this procedure still poses severe complications for some patients. Focused on tackling this treatment complication, researchers at the University of South Florida Health have recently developed a next-generation nanotherapy that consists of a nontoxic peptide and a synthetic messenger RNA (mRNA). The peptide and the mRNA spontaneously self-assemble into compacted nanoparticles that specifically target the injured regions of the arteries in mouse models mimicking angioplasty. The nanoparticles can also contain a microRNA switch, which can be added to the mRNA. The nanoparticles were injected into mice with arteries mimicking post-angioplasty vessel injury every three days for two weeks. Mice treated with the nanoparticles containing the microRNA switch completely restored endothelial cell growth in the injured artery, compared to animals treated with nanoparticles containing mRNA without the microRNA switch.
An official website of the United States government.